Whitegate Investment Counselors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-22,875
| Closed | -$13.1M | – | 198 |
|
|
2021
Q3 | $13.1M | Sell |
22,875
-577
| -2% | -$330K | 1.85% | 15 |
|
|
2021
Q2 | $11.8M | Sell |
23,452
-254
| -1% | -$128K | 1.68% | 17 |
|
|
2021
Q1 | $10.8M | Sell |
23,706
-726
| -3% | -$331K | 1.65% | 18 |
|
|
2020
Q4 | $11.4M | Sell |
24,432
-1,545
| -6% | -$720K | 1.84% | 13 |
|
|
2020
Q3 | $11.5M | Sell |
25,977
-1,465
| -5% | -$647K | 2.09% | 11 |
|
|
2020
Q2 | $9.94M | Sell |
27,442
-184
| -0.7% | -$66.7K | 1.99% | 14 |
|
|
2020
Q1 | $7.84M | Sell |
27,626
-1,872
| -6% | -$531K | 1.9% | 13 |
|
|
2019
Q4 | $9.58M | Sell |
29,498
-876
| -3% | -$285K | 1.74% | 12 |
|
|
2019
Q3 | $8.85M | Sell |
30,374
-1,393
| -4% | -$406K | 1.74% | 12 |
|
|
2019
Q2 | $9.33M | Sell |
31,767
-745
| -2% | -$219K | 1.88% | 10 |
|
|
2019
Q1 | $8.9M | Sell |
32,512
-400
| -1% | -$109K | 1.84% | 10 |
|
|
2018
Q4 | $7.37M | Sell |
32,912
-721
| -2% | -$161K | 1.7% | 13 |
|
|
2018
Q3 | $8.21M | Sell |
33,633
-1,165
| -3% | -$284K | 1.67% | 13 |
|
|
2018
Q2 | $7.21M | Sell |
34,798
-500
| -1% | -$104K | 1.47% | 17 |
|
|
2018
Q1 | $7.29M | Sell |
35,298
-685
| -2% | -$141K | 1.55% | 16 |
|
|
2017
Q4 | $6.83M | Sell |
35,983
-595
| -2% | -$113K | 1.43% | 19 |
|
|
2017
Q3 | $6.92M | Sell |
36,578
-420
| -1% | -$79.5K | 1.53% | 16 |
|
|
2017
Q2 | $6.46M | Sell |
36,998
-560
| -1% | -$97.7K | 1.46% | 17 |
|
|
2017
Q1 | $5.77M | Sell |
37,558
-730
| -2% | -$112K | 1.39% | 19 |
|
|
2016
Q4 | $5.4M | Sell |
38,288
-467
| -1% | -$65.9K | 1.45% | 19 |
|
|
2016
Q3 | $6.16M | Sell |
38,755
-2,920
| -7% | -$464K | 1.68% | 16 |
|
|
2016
Q2 | $6.16M | Buy |
+41,675
| New | +$6.16M | 1.71% | 14 |
|
|
2014
Q1 | $5.85M | Buy |
+41,316
| New | +$5.85M | 1.6% | 16 |
|